QuidelOrtho Upgrades Athens County, Ohio, Operations
02/13/2024
The investment will include machinery, equipment, and renovations. The new production line will produce a molecular platform that is designed to allow versatility, speed, and lab-quality results. The facility currently makes a variety of test kits from start to finish.
“QuidelOrtho’s decision to choose Athens to establish a new healthcare manufacturing product line demonstrates the value proposition that Ohio provides to innovative West Coast companies,” said JP Nauseef, President and CEO of JobsOhio. “The expansion reinforces the strength of Ohio’s burgeoning biohealth industry and confirms QuidelOrtho’s confidence in the region’s talented workforce.”
The project is being supported by a $750,000 JobsOhio Revitalization Grant. The JobsOhio Revitalization Program offers loans and grants to bridge the financial gap between the appealing cost of brownfield sites and the cost of site redevelopment.
“This is a major victory for Southeast Ohio,” noted OhioSE Vice President Katy Farber. “We are immensely grateful to QuidelOrtho for choosing our region and creating well-paying jobs. Their substantial investment underscores the unique potential our community offers.”
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products. In 2010, the company acquired Athens-based Diagnostic Hybrids.
“QuidelOrtho continues to be a success story for Athens County,” added Mollie Fitzgerald, Executive Director of Athens County Economic Development Council. “We are excited to support their growth in our community and the jobs and investment that come with that growth.”
Project Announcements
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
First Quality Home Care Products Plans Archbold, Ohio, Production Facility
03/08/2026
PPG Expands Delaware, Ohio, Manufacturing Operations
03/08/2026
J.M. Smucker Company Expands Topeka, Kansas, Operations
03/05/2026
Novartis Gene Therapies Plans Denton, Texas, Operations
03/04/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025